244 related articles for article (PubMed ID: 31359288)
1. Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.
Tam S; Gross ND
Curr Oncol Rep; 2019 Jul; 21(9):82. PubMed ID: 31359288
[TBL] [Abstract][Full Text] [Related]
2. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
3. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
Elghouche AN; Pflum ZE; Schmalbach CE
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
Varra V; Woody NM; Reddy C; Joshi NP; Geiger J; Adelstein DJ; Burkey BB; Scharpf J; Prendes B; Lamarre ED; Lorenz R; Gastman B; Manyam BV; Koyfman SA
Anticancer Res; 2018 Oct; 38(10):5825-5830. PubMed ID: 30275206
[TBL] [Abstract][Full Text] [Related]
6. Update on the management of high-risk squamous cell carcinoma.
LeBoeuf NR; Schmults CD
Semin Cutan Med Surg; 2011 Mar; 30(1):26-34. PubMed ID: 21540018
[TBL] [Abstract][Full Text] [Related]
7. Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.
Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Forstner D; Fowler A; Lee M; Kernohan M; Ngo Q; Estall V; Ebrahimi A
ANZ J Surg; 2019 Jul; 89(7-8):863-867. PubMed ID: 30974495
[TBL] [Abstract][Full Text] [Related]
8. Head and Neck Cutaneous Squamous Cell Carcinoma Clinicopathological Risk Factors according to Age and Gender: A Population-based Study.
Wiser I; Scope A; Azriel D; Zloczower E; Carmel NN; Shalom A
Isr Med Assoc J; 2016 May; 18(5):275-8. PubMed ID: 27430083
[TBL] [Abstract][Full Text] [Related]
9. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
10. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
[TBL] [Abstract][Full Text] [Related]
11. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.
Bottomley MJ; Thomson J; Harwood C; Leigh I
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022866
[TBL] [Abstract][Full Text] [Related]
12. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
13. Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals.
Feldmeyer L; Ching G; Vin H; Ma W; Bansal V; Chitsazzadeh V; Jahan-Tigh R; Chu EY; Fuller P; Maiti S; Davis RE; Cooper LJ; Tsai KY
Exp Dermatol; 2016 Mar; 25(3):245-7. PubMed ID: 26475987
[No Abstract] [Full Text] [Related]
14. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
15. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology.
Skulsky SL; O'Sullivan B; McArdle O; Leader M; Roche M; Conlon PJ; O'Neill JP
Head Neck; 2017 Mar; 39(3):578-594. PubMed ID: 27882625
[TBL] [Abstract][Full Text] [Related]
16. Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma.
Solares CA; Boyle GM; Brown I; Parsons PG; Panizza B
Otolaryngol Head Neck Surg; 2010 Mar; 142(3 Suppl 1):S15-9. PubMed ID: 20176274
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression and skin cancer: pathogenetic insights, therapeutic challenges, and opportunities for innovation.
Otley CC
Arch Dermatol; 2002 Jun; 138(6):827-8. PubMed ID: 12056967
[No Abstract] [Full Text] [Related]
18. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinoma of the scalp in the immunocompromised patient: review of 53 cases.
Kadakia S; Ducic Y; Marra D; Chan D; Saman M; Sawhney R; Mourad M
Oral Maxillofac Surg; 2016 Jun; 20(2):171-5. PubMed ID: 26780196
[TBL] [Abstract][Full Text] [Related]
20. Skin cancer in immunosuppressed patients.
Gordon Spratt EA; Carucci JA
Facial Plast Surg; 2013 Oct; 29(5):402-10. PubMed ID: 24037934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
